Craig A Johnson Odonate Therapeutics, Inc. (ODTC) insider trading activity

ODTC Quotes by TradingView

Craig A Johnson is Director of Odonate Therapeutics, Inc.. Currently has a direct ownership of 3,000 shares of ODTC, which is worth approximately $450 Million. The most recent transaction as insider was on Dec 29, 2020, when has been sold 3,000 shares (Common Stock) at a price of $17.0 per share, resulting in proceeds of $51,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3K
0% 3M change
0% 12M change
Total Value Held $450 Million

Craig A Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 29 2020
BUY
Open market or private purchase
$51,000 $17.0 p/Share
3,000 Added 50.0%
3,000 Common Stock

Also insider at

LJPC
LA JOLLA PHARMACEUTICAL CO Healthcare
Director
HRTX
HERON THERAPEUTICS, INC. Healthcare
MRTX
Mirati Therapeutics, Inc. Healthcare
AUPH
Aurinia Pharmaceuticals Inc. Healthcare
Director
CAJ

Craig A Johnson

Director
Waltham, MA

Track Institutional and Insider Activities on ODTC

Follow Odonate Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ODTC shares.

Notify only if

Insider Trading

Get notified when an Odonate Therapeutics, Inc. insider buys or sells ODTC shares.

Notify only if

News

Receive news related to Odonate Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ODTC